Truncated activin type II receptors inhibit bioactivity by the formation of heteromeric complexes with activin type I. receptors.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Experimental Cell Research

• Publication date

  1996-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1006/EXCR.1996.0142PMID 8612709
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Signaling Activity of Homologous and Heterologous Transforming Growth Factor-β Receptor Kinase Complexes (*)

  1995cited by this paper
• Cloning of a Novel Type II Serine/Threonine Kinase Receptor through Interaction with the Type I Transforming Growth Factor-β Receptor (*)

  1995cited by this paper
• Cloning and characterization of a human type II receptor for bone morphogenetic proteins.

  1995cited by this paper
• Human type II receptor for bone morphogenic proteins (BMPs): extension of the two-kinase receptor model to the BMPs

  1995cited by this paper
• Mechanism of activation of the TGF-beta receptor.

  1994cited by this paper
• Cloning, expression, and alternative splicing of the receptor for anti-Müllerian hormone.

  1994cited by this paper
• The types II and III transforming growth factor-beta receptors form homo-oligomers

  1994cited by this paper
• Formation of hetero-oligomeric complexes of type I and type II receptors for transforming growth factor-beta.

  1994cited by this paper
• Characterization of type I receptors for transforming growth factor-beta and activin.

  1994cited by this paper
• A novel member of the transmembrane serine/threonine kinase receptor family is specifically expressed in the gonads and in mesenchymal cells adjacent to the müllerian duct.

  1994cited by this paper
• Type I receptors specify growth-inhibitory and transcriptional responses to transforming growth factor beta and activin

  1994cited by this paper
• Activin receptors and cellular signaling by the receptor serine kinase family.

  1994cited by this paper
• Endoglin forms a heteromeric complex with the signaling receptors for transforming growth factor-beta.

  1994cited by this paper
• Effects of truncated activin and FGF receptors and of follistatin on the inducing activities of BVg1 and activin: does activin play a role in mesoderm induction?

  1994cited by this paper
• Inhibition of activin receptor signaling promotes neuralization in Xenopus.

  1994cited by this paper
• Homomeric interactions between type II transforming growth factor-beta receptors.

  1994cited by this paper
• Cloning of a type I TGF-beta receptor and its effect on TGF-beta binding to the type II receptor.

  1993cited by this paper
• Determination of type I receptor specificity by the type II receptors for TGF-beta or activin.

  1993cited by this paper
• Activin receptor-like kinases: a novel subclass of cell-surface receptors with predicted serine/threonine kinase activity.

  1993cited by this paper
• Cloning of a TGF beta type I receptor that forms a heteromeric complex with the TGF beta type II receptor.

  1993cited by this paper
• Identification of a Drosophila activin receptor.

  1993cited by this paper
• Betaglycan presents ligand to the TGF beta signaling receptor.

  1993cited by this paper
• Cloning and characterization of a transmembrane serine kinase that acts as an activin type I receptor.

  1993cited by this paper
• TGF beta signals through a heteromeric protein kinase receptor complex.

  1992cited by this paper
• Differential expression of inhibin subunits and follistatin, but not of activin receptor type II, during early murine embryonic development.

  1992cited by this paper
• Expression cloning of the TGF-beta type II receptor, a functional transmembrane serine/threonine kinase.

  1992cited by this paper
• Functional expression and growth factor activation of an epitope-tagged p44 mitogen-activated protein kinase, p44mapk.

  1992cited by this paper
• Isolation and characterization of native activin B.

  1992cited by this paper
• Novel activin receptors: distinct genes and alternative mRNA splicing generate a repertoire of serine/threonine kinase receptors.

  1992cited by this paper
• A truncated activin receptor inhibits mesoderm induction and formation of axial structures in Xenopus embryos

  1992cited by this paper
• Expression cloning of an activin receptor, a predicted transmembrane serine kinase.

  1991cited by this paper
• Identification of regulatory sequences in the type 1 plasminogen activator inhibitor gene responsive to transforming growth factor beta.

  1991cited by this paper
• Differentiation of aggregated murine P19 embryonal carcinoma cells is induced by a novel visceral endoderm-specific FGF-like factor and inhibited by activin A.

  1991cited by this paper
• Expression cloning and characterization of the TGF-beta type III receptor.

  1991cited by this paper
• Structure and expression of the membrane proteoglycan betaglycan, a component of the TGF-beta receptor system.

  1991cited by this paper
• Activin/EDF as an inhibitor of neural differentiation.

  1990cited by this paper
• Graded changes in dose of a Xenopus activin A homologue elicit stepwise transitions in embryonic cell fate

  1990cited by this paper
• Identification of a potent Xenopus mesoderm-inducing factor as a homologue of activin A

  1990cited by this paper
• Activin-like factor from a Xenopus laevis cell line responsible for mesoderm induction

  1990cited by this paper
• Gonadal and extragonadal expression of inhibin alpha, beta A, and beta B subunits in various tissues predicts diverse functions.

  1988cited by this paper
• Purification and characterization of erythroid differentiation factor (EDF) isolated from human leukemia cell line THP-1.

  1987cited by this paper
• A human beta-actin expression vector system directs high-level accumulation of antisense transcripts.

  1987cited by this paper
• Pituitary FSH is released by a heterodimer of the β-subunits from the two forms of inhibin

  1986cited by this paper
• Purification and characterization of an FSH releasing protein from porcine ovarian follicular fluid

  1986cited by this paper
• Complementary DNA sequences of ovarian follicular fluid inhibin show precursor structure and homology with transforming growth factor-β

  1985cited by this paper
• Monoclonal antibodies specific for the carboxy terminus of simian virus 40 large T antigen

  1984cited by this paper

• Exploring the Myostatin Activation Pathway: A Promising Target for Treating Muscle Atrophy

  2025cites this paper
• Whole exome sequencing analysis in severe chronic obstructive pulmonary disease

  2018cites this paper
• Diagnostic value of serum activin A and follistatin levels in women with peritoneal, ovarian and deep infiltrating endometriosis.

  2012cites this paper
• Feedback regulation by inhibins A and B of the pituitary secretion of follicle-stimulating hormone.

  2011cites this paper
• Identification of BMP9 and BMP10 as functional activators of the orphan activin receptor-like kinase 1 (ALK1) in endothelial cells.

  2007cites this paper
• Prevention of cachexia-like syndrome development and reduction of tumor progression in inhibin-deficient mice following administration of a chimeric activin receptor type II-murine Fc protein.

  2007cites this paper
• Identification of BMP 9 and BMP 10 as functional activators of the orphan activin receptor-like kinase 1 ( ALK 1 ) in endothelial cells

  2007cites this paper
• Molecular correlates of site-specific metastasis.

  2006cites this paper
• Alternative Polyadenylation Results in a Truncated daf-4 BMP Receptor That Antagonizes DAF-7-mediated Development in Caenorhabditis elegans*

  2004cites this paper
• Neonatal oestrogen treatment and effects on the hypothalamic-pituitary-gonadal axis

  2003cites this paper
• Activin receptor-like kinase 1 is implicated in the maturation phase of angiogenesis.

  2002cites this paper
• Autosomal recessive segregation of a truncating mutation of anti-Müllerian type II receptor in a family affected by the persistent Müllerian duct syndrome contrasts with its dominant negative activity in vitro.

  2001cites this paper
• A Caenorhabditis elegans type I TGF beta receptor can function in the absence of type II kinase to promote larval development.

  2000cites this paper
• Activin A-induced HepG2 liver cell apoptosis: involvement of activin receptors and smad proteins.

  2000cites this paper
• Hereditary hemorrhagic telangiectasia: A model for blood vessel growth and enlargement.

  2000cites this paper
• Truncated activin type I receptor Alk4 isoforms are dominant negative receptors inhibiting activin signaling.

  2000cites this paper
• Bone morphogenetic proteins (BMPs) induce epithelial differentiation of NT2D1 human embryonal carcinoma cells.

  2000cites this paper
• Truncated activin type II receptor inhibits erythroid differentiation in K562 cells

  2000cites this paper
• Activin and inhibin binding to the soluble extracellular domain of activin receptor II.

  1999cites this paper
• Developmental tumours, early differentiation and the transforming growth factor beta superfamily.

  1999cites this paper
• Assignment of transforming growth factor beta1 and beta3 and a third new ligand to the type I receptor ALK-1.

  1999cites this paper
• Retained Müllerian Ducts

  1999cites this paper
• Assignment of Transforming Growth Factor β1 and β3 and a Third New Ligand to the Type I Receptor ALK-1*

  1999cites this paper
• Mouse embryonic stem cells with aberrant transforming growth factor beta signalling exhibit impaired differentiation in vitro and in vivo.

  1998cites this paper
• Regulation of cellular and system function by activin.

  1998cites this paper
• DPC4 (SMAD4) mediates transforming growth factor-β1 (TGF-β1) induced growth inhibition and transcriptional response in breast tumour cells

  1997cites this paper
• Activin Signal Transduction and the Role of TGF-β Superfamily in Cell Differentiation

  1997cites this paper
• Expression of ALK‐1, a type 1 serine/threonine kinase receptor, coincides with sites of vasculogenesis and angiogenesis in early mouse development

  1997cites this paper
• Serine/threonine kinase receptors and ligands.

  1997cites this paper
• Activin and basic fibroblast growth factor regulate neurogenesis of murine embryonal carcinoma cells.

  1996cites this paper
• [Activin: diversity of functions and signal transduction].

  1996cites this paper